[
    "**Active induction of experimental autoimmune uveoretinitis \\(EAU)**",
    "EAU was induced with 150&#xB5;g bovine IRBP and 300&#xB5;g human IRBP peptide \\(1-20) in C57bl/6 strain.",
    "Disease was induced in B10RIII mice with 150&#xB5;g bovine IRBP and 12-20 &#xB5;g human IRBP peptide \\(161-180) and clinical disease in both strains were established by fundoscopy and histology.",
    "Initial signs EAU is observed approximately 7-12 days after immunization, with full-blown disease developing by post-immunization day-14.",
    "By day-21 post-immunization there is substantial reduction of inflammatory cells and disease resolution characterized by absence of inflammatory cells or inflammatory cytokines in the retina occurs 28 days post-immunization<sup>6</sup>. ",
    "**Preparation of antigen/CFA emulsion**",
    "1|  ",
    "Into a 50 ml polypropylene tube, ",
    "Add 0.5 ml stock bovine IRBP protein \\(6 mg/ml) and 6 mg lyophilized human IRBP peptide \\(1-20) and ",
    "Bring mixture to a final volume of 2 ml",
    "2|  Add an equal volume or 2 ml of Complete Freund adjuvant \\(CFA) containing Mycobacterium tuberculosis strain H37Ra \\(2.5",
    "mg/ml), ",
    "Mix and chill on ice for 10 min",
    "3|  Sonicate at high speed on ice for 20 seconds followed by 30 seconds intervals ",
    "4|  Repeat 4-5 times until the mixture appears as a thick white cream.",
    "5|  Centrifuge at 1200 RPM for 1 min.",
    "6|  ",
    "Prepare CFA emulsion without IRBP to serve as control.",
    "7|  Transfer emulsion into in 1 ml syringes with 19 gauge blunt-ended needles ",
    "8|  Prepare PTX \\(2 ug/ml) solution in 1 ml syringes with 25 gauge needles ",
    "**Immunization** ",
    "1|  Prepare sufficient PTX \\(2 ug/ml) solution \\(100&#xB5;l/mouse) ",
    "2|  ",
    "Prepare sufficient CFA/Antigen emulsions \\(200&#xB5;l/mouse)",
    "3|  ",
    "Before injections expel any air bubble in the syringe containing PTX or emulsion",
    "4|  Inject each mouse with PTX solution \\(100 &#xB5;l) intraperitoneally",
    "5|  Inject emulsion subcutaneously into base of tail \\(100 &#xB5;l) and each thigh \\(50 &#xB5;l) ",
    "6|  Sacrifice the immunized at post-immunization day-7, -14, -21, and -28.",
    "Controls: Un-immunized WT mice;",
    "mice immunized with CFA emulsion \\(without IRBP)",
    "**Clinical grading of mice with EAU by fundoscopy**",
    "1|  ",
    "Restrain mice by anethesia: intraperitoneal injection of mixture of Ketamine and xylazine \\(Rompun) at 30 mg/kg and 9 mg/kg, respectively. ",
    "2|  ",
    "After 5-10 min, dilate pupils by applying 1 ",
    "Drop of Mydriacyl \\(1%) to each eye. ",
    "3|  Gently press the ",
    "Cover glass on the cornea.",
    "4|  ",
    "Adjust head ",
    "Position to focus retina to the fundoscope for examination ",
    "**Note**: Mydriacyl causes temporary lens opacification within 15-20 min after application; it is important to complete examination within this time. ",
    "**Preparation of sections for ocular histology**",
    "1|  Incubate enucleated eyes overnight in 10% buffered formaldehyde",
    "2|  Embed eyes and ",
    "Cut 5&#xB5;M paraffin sections in anterior/posterior orientation.",
    "3|  Stain sections in hematoxylin &amp; eosin \\(H&amp;E). ",
    "4|  ",
    "Grading of EAU pathology is as previously described. ",
    "**Inhibition of EAU by IL-17 neutralizing antibody**",
    "1|  Active immunization of C57BL/6 mice with IRBP in CFA ",
    "2|  Dilute IL-17 or IgD2a isotype control antibodies in PBS",
    "3|  Inject 500 &#xB5;l IL-17 antibody \\(350 &#xB5;g) intraperitoreally into treatment group \\(4 mice) 1 day before immunization with IRBP/CFA emulsion \\(day -1). ",
    "4|  Inject 500 &#xB5;l IgD2a isotype control antibody \\(350 &#xB5;g) intraperitoreally into control group \\(4 mice) 1 day before immunization with IRBP/CFA emulsion \\(day -1).",
    "5|  Repeat Ab injection every other day until day 17 post-immunization. ",
    "6|  Perform fundscopic examinations at post-immunization days 12, 14 and 16. ",
    "7|  Sacrifice mice at post-immunization day-19 and ",
    "Perform histology",
    "**IL-27 expression in PBMC or retina is temporally correlated with progression of EAU**",
    "1|  Immunise mice \\(8) with CFA or IRBP/CFA emulsion",
    "2|  ",
    "Monitor EAU progression by fundoscopy and histology",
    "3|  Sacrifice mice at post-immunization days, 0, 7, 14, 21 and 28 ",
    "4|  Section 1 eye for histology and ",
    "Stain with H&amp;E ",
    "5|  Isolate RNA and protein extracts from retina, PBMC or lymph nodes",
    "6|  Analyze IL-27 protein expression by Western blotting",
    "7|  Analyze IL27 and Ebi3 expression by RT-PCR and qPCR."
]